Bispecific and split CAR T cells targeting CD13 and TIM3 eradicate acute myeloid leukemia

Chimeric antigen receptor (CAR) T cells have radically improved the treatment of B cell–derived malignancies by targeting CD19. The success has not yet expanded to treat acute myeloid leukemia (AML). We developed a Sequentially Tumor-Selected Antibody and Antigen Retrieval (STAR) system to rapidly i...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Blood
Egile Nagusiak: He, Xin, Feng, Zijie, Ma, Jian, Ling, Sunbin, Cao, Yan, Gurung, Buddha, Wu, Yuan, Katona, Bryson W., O’Dwyer, Kienan P., Siegel, Don L., June, Carl H., Hua, Xianxin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society of Hematology 2020
Gaiak:
Plenary Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059518/
https://ncbi.nlm.nih.gov/pubmed/31951650
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019002779
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak